Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines

ABSTRACT Candida albicans has developmental programs that govern transitions between yeast and filamentous morphologies and between unattached and biofilm lifestyles. Here, we report that filamentation, intercellular adherence, and biofilm development were inhibited during interactions between Candi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Diana K. Morales, Nora Grahl, Chinweike Okegbe, Lars E. P. Dietrich, Nicholas J. Jacobs, Deborah A. Hogan
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2013
Materias:
Acceso en línea:https://doaj.org/article/6f2c7f41a4284406bf7ecdf177e66c8d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f2c7f41a4284406bf7ecdf177e66c8d
record_format dspace
spelling oai:doaj.org-article:6f2c7f41a4284406bf7ecdf177e66c8d2021-11-15T15:40:23ZControl of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines10.1128/mBio.00526-122150-7511https://doaj.org/article/6f2c7f41a4284406bf7ecdf177e66c8d2013-03-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00526-12https://doaj.org/toc/2150-7511ABSTRACT Candida albicans has developmental programs that govern transitions between yeast and filamentous morphologies and between unattached and biofilm lifestyles. Here, we report that filamentation, intercellular adherence, and biofilm development were inhibited during interactions between Candida albicans and Pseudomonas aeruginosa through the action of P. aeruginosa-produced phenazines. While phenazines are toxic to C. albicans at millimolar concentrations, we found that lower concentrations of any of three different phenazines (pyocyanin, phenazine methosulfate, and phenazine-1-carboxylate) allowed growth but affected the development of C. albicans wrinkled colony biofilms and inhibited the fungal yeast-to-filament transition. Phenazines impaired C. albicans growth on nonfermentable carbon sources and led to increased production of fermentation products (ethanol, glycerol, and acetate) in glucose-containing medium, leading us to propose that phenazines specifically inhibited respiration. Methylene blue, another inhibitor of respiration, also prevented the formation of structured colony biofilms. The inhibition of filamentation and colony wrinkling was not solely due to lowered extracellular pH induced by fermentation. Compared to smooth, unstructured colonies, wrinkled colony biofilms had higher oxygen concentrations within the colony, and wrinkled regions of these colonies had higher levels of respiration. Together, our data suggest that the structure of the fungal biofilm promotes access to oxygen and enhances respiratory metabolism and that the perturbation of respiration by bacterial molecules such as phenazines or compounds with similar activities disrupts these pathways. These findings may suggest new ways to limit fungal biofilms in the context of disease. IMPORTANCE Many of the infections caused by Candida albicans, a major human opportunistic fungal pathogen, involve both morphological transitions and the formation of surface-associated biofilms. Through the study of C. albicans interactions with the bacterium Pseudomonas aeruginosa, which often coinfects with C. albicans, we have found that P. aeruginosa-produced phenazines modulate C. albicans metabolism and, through these metabolic effects, impact cellular morphology, cell-cell interactions, and biofilm formation. We suggest that the structure of C. albicans biofilms promotes access to oxygen and enhances respiratory metabolism and that the perturbation of respiration by phenazines inhibits biofilm development. Our findings not only provide insight into interactions between these species but also provide valuable insights into novel pathways that could lead to the development of new therapies to treat C. albicans infections.Diana K. MoralesNora GrahlChinweike OkegbeLars E. P. DietrichNicholas J. JacobsDeborah A. HoganAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 4, Iss 1 (2013)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Diana K. Morales
Nora Grahl
Chinweike Okegbe
Lars E. P. Dietrich
Nicholas J. Jacobs
Deborah A. Hogan
Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines
description ABSTRACT Candida albicans has developmental programs that govern transitions between yeast and filamentous morphologies and between unattached and biofilm lifestyles. Here, we report that filamentation, intercellular adherence, and biofilm development were inhibited during interactions between Candida albicans and Pseudomonas aeruginosa through the action of P. aeruginosa-produced phenazines. While phenazines are toxic to C. albicans at millimolar concentrations, we found that lower concentrations of any of three different phenazines (pyocyanin, phenazine methosulfate, and phenazine-1-carboxylate) allowed growth but affected the development of C. albicans wrinkled colony biofilms and inhibited the fungal yeast-to-filament transition. Phenazines impaired C. albicans growth on nonfermentable carbon sources and led to increased production of fermentation products (ethanol, glycerol, and acetate) in glucose-containing medium, leading us to propose that phenazines specifically inhibited respiration. Methylene blue, another inhibitor of respiration, also prevented the formation of structured colony biofilms. The inhibition of filamentation and colony wrinkling was not solely due to lowered extracellular pH induced by fermentation. Compared to smooth, unstructured colonies, wrinkled colony biofilms had higher oxygen concentrations within the colony, and wrinkled regions of these colonies had higher levels of respiration. Together, our data suggest that the structure of the fungal biofilm promotes access to oxygen and enhances respiratory metabolism and that the perturbation of respiration by bacterial molecules such as phenazines or compounds with similar activities disrupts these pathways. These findings may suggest new ways to limit fungal biofilms in the context of disease. IMPORTANCE Many of the infections caused by Candida albicans, a major human opportunistic fungal pathogen, involve both morphological transitions and the formation of surface-associated biofilms. Through the study of C. albicans interactions with the bacterium Pseudomonas aeruginosa, which often coinfects with C. albicans, we have found that P. aeruginosa-produced phenazines modulate C. albicans metabolism and, through these metabolic effects, impact cellular morphology, cell-cell interactions, and biofilm formation. We suggest that the structure of C. albicans biofilms promotes access to oxygen and enhances respiratory metabolism and that the perturbation of respiration by phenazines inhibits biofilm development. Our findings not only provide insight into interactions between these species but also provide valuable insights into novel pathways that could lead to the development of new therapies to treat C. albicans infections.
format article
author Diana K. Morales
Nora Grahl
Chinweike Okegbe
Lars E. P. Dietrich
Nicholas J. Jacobs
Deborah A. Hogan
author_facet Diana K. Morales
Nora Grahl
Chinweike Okegbe
Lars E. P. Dietrich
Nicholas J. Jacobs
Deborah A. Hogan
author_sort Diana K. Morales
title Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines
title_short Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines
title_full Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines
title_fullStr Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines
title_full_unstemmed Control of <named-content content-type="genus-species">Candida albicans</named-content> Metabolism and Biofilm Formation by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Phenazines
title_sort control of <named-content content-type="genus-species">candida albicans</named-content> metabolism and biofilm formation by <named-content content-type="genus-species">pseudomonas aeruginosa</named-content> phenazines
publisher American Society for Microbiology
publishDate 2013
url https://doaj.org/article/6f2c7f41a4284406bf7ecdf177e66c8d
work_keys_str_mv AT dianakmorales controlofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontentmetabolismandbiofilmformationbynamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontentphenazines
AT noragrahl controlofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontentmetabolismandbiofilmformationbynamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontentphenazines
AT chinweikeokegbe controlofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontentmetabolismandbiofilmformationbynamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontentphenazines
AT larsepdietrich controlofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontentmetabolismandbiofilmformationbynamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontentphenazines
AT nicholasjjacobs controlofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontentmetabolismandbiofilmformationbynamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontentphenazines
AT deborahahogan controlofnamedcontentcontenttypegenusspeciescandidaalbicansnamedcontentmetabolismandbiofilmformationbynamedcontentcontenttypegenusspeciespseudomonasaeruginosanamedcontentphenazines
_version_ 1718427770247184384